publication venue for
- MASP2 inhibition by narsoplimab suppresses endotheliopathies characteristic of transplant-associated thrombotic microangiopathy: in vitro and ex vivo evidence. 2023
- Heterosubtypic, cross-reactive immunity to human Cytomegalovirus glycoprotein B. 2022
- MASP2 levels are elevated in thrombotic microangiopathies: association with microvascular endothelial cell injury and suppression by anti-MASP2 antibody narsoplimab.. 203. 2020
- Low frequency, weak MCP-1 secretion and exhausted immune status of peripheral monocytes were associated with progression of severe enterovirus A71-infected hand, foot and mouth disease.. 196. 2019
- Skin resident memory CD8+ T cells are phenotypically and functionally distinct from circulating populations and lack immediate cytotoxic function.. 194. 2018
- HE4 suppresses the expression of osteopontin in mononuclear cells and compromises their cytotoxicity against ovarian cancer cells.. 193. 2018
- Immunoglobulin (Ig)M antibodies to proteinase 3 in granulomatosis with polyangiitis and microscopic polyangiitis.. 188. 2017
- Expression of type III interferons (IFNλs) and their receptor in Sjögren's syndrome.. 186. 2016
- Soluble and membrane-bound interleukin (IL)-15 Rα/IL-15 complexes mediate proliferation of high-avidity central memory CD8+ T cells for adoptive immunotherapy of cancer and infections.. 186. 2016
- The impact of disease activity and tumour necrosis factor-α inhibitor therapy on cytokine levels in juvenile idiopathic arthritis.. 184. 2016
- RGD capsid modification enhances mucosal protective immunity of a non-human primate adenovirus vector expressing Pseudomonas aeruginosa OprF.. 173. 2013
- Optimizing dendritic cell vaccine for immunotherapy in multiple myeloma: tumour lysates are more potent tumour antigens than idiotype protein to promote anti-tumour immunity.. 170. 2012
- Lower numbers of circulating Natural Killer T (NK T) cells in individuals with human T lymphotropic virus type 1 (HTLV-1) associated neurological disease.. 158. 2009
- Immunoglobulin E antibodies from pancreatic cancer patients mediate antibody-dependent cell-mediated cytotoxicity against pancreatic cancer cells.. 153. 2008
- Interactions among human immunodeficiency virus (HIV)-1, interferon-gamma and receptor of activated NF-kappa B ligand (RANKL): implications for HIV pathogenesis.. 137. 2004
- CD56(+dim) and CD56(+bright) cell activation and apoptosis in hepatitis C virus infection.. 137. 2004
- T cell receptor VB repertoire diversity in patients with immune thrombocytopenia following splenectomy.. 133. 2003
- Anti-platelet antibodies associated with the Canale-Smith syndrome bind to the same platelet glycoprotein complexes as those of idiopathic thrombocytopenic purpura patients.. 127. 2002
- Synergistic mechanisms by which sirolimus and cyclosporin inhibit rat heart and kidney allograft rejection.. 108. 1997
- Idiotype-induced T cell stimulation requires antigen presentation in association with HLA-DR molecules.. 104. 1996
- T and B lymphocytes reacting with the extracellular loop of the beta 2-adrenergic receptor (beta 2AR) are present in the peripheral blood of patients with myasthenia gravis.. 103. 1996
- Ontogeny and induction of adhesion molecule expression in human fetal intestine.. 91. 1993
- MRL/lpr-->severe combined immunodeficiency mouse allografts produce autoantibodies, acute graft-versus-host disease or a wasting syndrome depending on the source of cells.. 90. 1992
- Treatment of patients with chronic granulomatous disease with recombinant human interferon-gamma does not improve neutrophil oxidative metabolism, cytochrome b558 content or levels of four anti-microbial proteins.. 88. 1992
- Analysis of autoantibody production in SCID-systemic lupus erythematosus (SLE) chimeras.. 88. 1992
- Acute shift in immune response to microbial activators in very-low-birth-weight infants.. 83. 1991
- Antigen-stimulated human interferon-gamma generation: role of accessory cells and their expressed or secreted products.. 77. 1989
- Interaction between fibronectin and C1q in rheumatoid synovial fluid and normal plasma.. 72. 1988
- Modulation of the defective natural killer activity seen in thalassaemia major with desferrioxamine and alpha-interferon.. 70. 1987
- Association of circulating immune complexes containing bovine proteins and graft-versus-host disease.. 64. 1986
- Selective activation of functional suppressor cells by human seminal fluid.. 64. 1986
- Immunological abnormalities in thalassaemia major. I. A transfusion-related increase in circulating cytoplasmic immunoglobulin-positive cells.. 62. 1985
- Cytokines and the chronic inflammation of rheumatic disease. II. The presence of interleukin-2 in synovial fluids.. 58. 1984
- Non-immune IgG binding to the surface of spermatozoa by disulphide rearrangement.. 58. 1984
- Increased expression of the C3b receptor by neutrophils and complement activation during haemodialysis.. 56. 1984
- Cytokines and the chronic inflammation of rheumatic disease. I. The presence of interleukin-1 in synovial fluids.. 55. 1984
- Induction of antibody to asialo GM1 by spermatozoa and its occurrence in the sera of homosexual men with the acquired immune deficiency syndrome (AIDS).. 54. 1983
- Fibronectin mediates cell attachment to C1q: a mechanism for the localization of fibrosis in inflammatory disease.. 54. 1983
- Circulating thymic hormone levels in severe combined immunodeficiency.. 53. 1983
- Human dendritic cells: major stimulators of the autologous and allogeneic mixed leucocyte reactions.. 49. 1982
- Demonstration of 11S IgA antibody to spermatozoa in human seminal fluid.. 44. 1981
- Demonstration of IgG Fc receptors on spermatozoa and their utilization for the detection of circulating immune complexes in human serum.. 41. 1980
- Receptors for immunoglobulin isotype on T and B lymphocytes from untreated patients with chronic lymphocytic leukaemia.. 40. 1980
- In vitro proliferation of macrophage depleted human peripheral blood lymphocytes.. 38. 1979
- Inhibition of viral reverse transcriptase and human sperm DNA polymerase by anti-sperm antibodies.. 33. 1978
- E-rosette inhibiting substance in Hodgkin's disease spleen extracts.. 29. 1977
- Leukocyte migration inhibitory factor (LMIF) profile in primary and secondary immunodeficiency disease.. 26. 1976
- Heterogeneity of stem cells in severe combined immunodeficiency.. 25. 1976
- The use of cryopreserved lymphocytes for longitudinal studies of immune function and enumeration of subpopulations.. 25. 1976
- Clinical applications of intravenous immunoglobulins in neurology. 2009
- Anti-inflammatory and immunosuppressive effects of recombinant soluble complement receptors. 1991